You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Susceptibility Gene(s) for Thyroid Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Gene Hunting Study for Familial Papillary Thyroid Cancer

Recruiting
  • Thyroid
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 13, 2022

    Thyroid Nodule (Diagnosis), Thyroid Cancer Trial in Aarhus N (Molecular analyses)

    Enrolling by invitation
    • Thyroid Nodule (Diagnosis)
    • Thyroid Cancer
    • Molecular analyses
    • Aarhus N, Denmark
      Aarhus Universityhospital
    May 16, 2022

    Differentiated Thyroid Cancer, Thyroid Cancer, Nonmedullary Trial in La Roche-sur-Yon, Nantes (WGS)

    Recruiting
    • Differentiated Thyroid Cancer
    • Thyroid Cancer, Nonmedullary
    • WGS
    • La Roche-sur-Yon, France
    • +1 more
    Feb 25, 2022

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Thyroid Cancer, Papillary, Hypothyroidism Trial in Xiamen (L-T4, L-T4+T3 (thyroid tablet))

    Recruiting
    • Thyroid Cancer, Papillary
    • Hypothyroidism
    • L-T4
    • L-T4+T3 (thyroid tablet)
    • Xiamen, Fujian, China
      Yan Ling
    Feb 9, 2022

    Genetic Predisposition to Disease Trial in Paris, Cologne (BRIDGES gene panel testing, Breast cancer risk polygenic risk score

    Completed
    • Genetic Predisposition to Disease
    • BRIDGES gene panel testing
    • +2 more
    • Paris, France
    • +1 more
    Jan 19, 2023

    Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic

    Recruiting
    • Renal Tumor Histology
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 28, 2022

      Birt Hogg-Dube Syndrome and Characterization of Predisposition

      Recruiting
      • Kidney Neoplasms
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 22, 2022

        Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)

        Recruiting
        • Anaplastic Thyroid Cancer
        • +3 more
        • Basking Ridge, New Jersey
        • +6 more
        Jul 1, 2022

        Universal- Versus Guidelines-Directed Genetic Testing for

        Recruiting
        • Genetic Predisposition
          • Amman, Jordan
            King Hussein Cancer Center
          Aug 17, 2022

          Thyroid Tumors Trial in India (Lenvatinib)

          Active, not recruiting
          • Thyroid Neoplasms
          • New Delhi, Delhi, India
          • +10 more
          Jul 15, 2022

          Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

          Recruiting
          • Bone Sarcoma
          • +15 more
          • Aldesleukin
          • +8 more
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 3, 2022

          NSCLC, Thyroid Tumors Trial (LOXO-260)

          Temporarily not available
          • Carcinoma, Non-Small-Cell Lung
          • Thyroid Neoplasms
          • (no location specified)
          Sep 20, 2022

          Familial Non-medullary Thyroid Cancer

          Recruiting
          • Non-Medullary Thyroid Cancer
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Aug 24, 2022

            Advanced Breast Cancer Trial in Spain (Olaparib [Lynparza®] plus Trastuzumab [Herceptin®])

            Terminated
            • Advanced Breast Cancer
            • Olaparib [Lynparza®] plus Trastuzumab [Herceptin®]
            • Barcelona, Spain
            • +16 more
            Jan 18, 2023

            Genetic Predisposition to Disease, Breast Cancer Female, Ovarian Cancer Trial in Philadelphia (Sequential EHR Communications)

            Not yet recruiting
            • Genetic Predisposition to Disease
            • +6 more
            • Sequential EHR Communications
            • Philadelphia, Pennsylvania
              Abramson Cancer Center of the University of Pennsylvania
            Feb 8, 2023

            Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

            Active, not recruiting
            • Advanced Nonhaematologic Malignancies
            • Philadelphia, Pennsylvania
            • +20 more
            Sep 23, 2022

            Precision Medicine in the Prostate Cancer Care Pathway

            Recruiting
            • Prostate Cancer
            • Genetic Predisposition
            • Prostate cancer risk gene panel
            • Sutton, England, United Kingdom
              Royal Marsden Hosital,
            Mar 30, 2022

            Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

            Available
            • Pancreatic Cancer
            • +20 more
            • Ulixertinib (BVD-523)
            • Birmingham, Alabama
            • +25 more
            Nov 4, 2022

            Study of Clinical Outcomes of Thyroid Cancer

            Recruiting
            • Thyroid Neoplasms
            • Standard treatment
            • Ancona, Italy
            • +18 more
            Oct 28, 2021

            Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

            Recruiting
            • Solid Tumor
            • +11 more
            • Belfast, United Kingdom
            • +16 more
            Mar 2, 2023

            Called EPI VITRAKVI to Compare Treatment Results in Infantile

            Completed
            • Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
            • Infantile Fibrosarcoma
            • Larotrectinib (Vitrakvi, BAY2757556)
            • Standard of Care
            • Multiple Locations, France
              Multiple Locations
            Jan 10, 2023

            Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

            Recruiting
            • Prostatic Neoplasm
            • +7 more
            • Prostate cancer screening
            • Boston, Massachusetts
              Massachusetts General Hospital
            Nov 30, 2021

            Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

            Recruiting
            • Advanced Cancer
            • +24 more
            • pembrolizumab
            • Los Angeles, California
            • +21 more
            Jan 18, 2023

            Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)

            Recruiting
            • Pheochromocytoma
            • +7 more
            • Genetic screening
            • San Antonio, Texas
              University of Texas Health Science Center
            Aug 25, 2022